NEW YORK(GenomeWeb) — Danaher today initiated guidance for adjusted diluted EPS for 2015 in the range of $4.35 to $4.45. 

The guidance assumes core revenue growth of 3 percent to 4 percent and excludes anticipated non-cash amortization for 2015 of $440 million, or $.46 per share, compared to about $380 million, or $40 per share, in 2014.  

The company also reaffirmed GAAP diluted EPS for the fourth quarter of 2014 to be in the range of $1 to $1.04. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.